Guy Chamberland, M.Sc., Ph.D., Chief Executive Officer and Chief Scientific Officer

Portrait

Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, has served as Tetra Bio-Pharma’s Chief Executive Officer and Chief Scientific Officer since October 15, 2018. Previously he held the positions of Interim Chief Executive Officer and Chief Scientific Officer since April 2018 and June 2016, respectively. His extensive and broad-based experience in both executive and scientific roles establish Dr. Chamberland as a seasoned and knowledgeable professional in the biopharmaceutical space. Dr. Chamberland has over 22 years of experience in new drug development for the pharmaceutical industry (Canada and USA) with specific expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines. He also was a member of the investment committee of the venture capital fund, Fonds Bionvation, for 7 years.

Dr. Chamberland has become a recognized expert in the field of botanical medicine, publishing, lecturing and delivering continuing education workshops to health professionals on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing. He is a Professor of Botanical Medicine and Principles of Clinical Research at the École d’Enseignement Superieur de Naturopathie du Quebec (EESNQ) and French language equivalent of the Canadian College of Naturopathic Medicine (CCNNM). He earned a diploma in Proficiency in Herbal Prescription from the Australian College of Phytotherapy, and Certified Herbalist and Master Herbalist diplomas from the Dominion College of Canada. Dr. Chamberland received a B.Sc. in Agriculture from McGill University, an M.Sc. in Veterinary Anatomy and Physiology and a Ph.D. in Biomedical Sciences (toxicology) from the University of Montreal.

Richard Giguere, Chief Executive Officer – Tetra Natural Health Inc.

Portrait

Mr. Giguere has more than 20 years of national sales and marketing experience in the Canadian pharmaceutical industry from coast to coast. During his career, he has held various positions in business development, management and negotiation and launched several new products onto the Canadian market. He has worked for various pharmaceutical companies in sectors such as generics, branded products and medical devices. He has also worked with over the counter, natural products and original medications. Richard is recognized for his business ethics, respect for others and talent for developing long-term business relationships through flexibility and efficiency. Over the past 10 years, he was also a board member at the companies for which he worked.

Sabino Di Paola, Chief Financial Officer

Portrait

Mr. Di Paola has over a decade of experience in audit, finance and accounting as an auditor for PricewaterhouseCoopers and BDO Canada and has been involved with numerous financing and spin-out transactions. He is currently Chief Financial Officer for Mondias Natural Products and UrbanGold Minerals Inc., both publicly traded companies on the TSX Venture.

Robert Béchard, Executive Vice President, Corporate Development and Licensing

Portrait

Mr. Béchard brings more than 25 years of experience in finance, venture capital, corporate banking and business development experience to his role as Executive Vice President, Corporate Development and Licensing. Prior to joining Tetra, Mr. Béchard was a Senior Member at RBC Lifesciences, delivering top quartile returns for two separate venture capital funds with investments in American Biotech companies. During his 12-year term as a venture capitalist, Mr. Béchard, was involved in numerous investments, served on the Boards of more than 30 life science companies and oversaw the negotiation of numerous strategic alliances, partnerships, and outright sales to both pharmaceutical and biotech companies including taking several companies public both in Canada and the U.S. Mr. Béchard has also held key operating roles for an R&D management company and a drug delivery company contributing to their growth as well as serving as a consultant to the biopharmaceutical industry providing start-up assistance in areas of fundraising, strategy, and business and corporate development.

Steeve Néron, Senior Vice President, Marketing and Medical Affairs

Portrait

Mr. Néron has more than 32 years of experience in the pharmaceutical industry with demonstrated success in numerous therapeutic sectors including cardiology, rheumatology, endocrinology, women’s health, asthma/COPD, OTC and dermatology where challenging the reimbursement landscape factored prominently in his role. Prior to joining Tetra Bio-Pharma he occupied a senior marketing position at Bausch Health Canada, formerly Valeant. Steeve has held various marketing, sales, finance, material management and business development positions and has worked to launch or rejuvenate numerous market leading pharmaceutical brands including Aerius™ (antihistamine), Altace™ (hypertension), Ezetrol™ (cholesterol), Eliquis™ (anti-coagulant), Lodalis™ (cholesterol) and Contrave™ (Obesity).